Matches in SemOpenAlex for { <https://semopenalex.org/work/W1599591833> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W1599591833 abstract "The use of proteasome inhibition as a therapeutic target against human cancers represents an exciting new target either alone, or in combination with other agents. The use of single agent bortezomib in relapsed myeloma resulted in a 43% response rate, improved time to progression, and superior overall survival when compared with high dose dexamethasone in the randomized phase III APEX trial. This survival benefit continues to hold despite the cross-over use of bortezomib for patients initially randomized to receive dexamethasone, further solidifying the use of bortezomib as a standard approach for the management of relapsed myeloma." @default.
- W1599591833 created "2016-06-24" @default.
- W1599591833 creator A5023276777 @default.
- W1599591833 date "2009-06-08" @default.
- W1599591833 modified "2023-09-28" @default.
- W1599591833 title "Practical issues involved with the use of bortezomib" @default.
- W1599591833 doi "https://doi.org/10.4081/hmr.v2i7.408" @default.
- W1599591833 hasPublicationYear "2009" @default.
- W1599591833 type Work @default.
- W1599591833 sameAs 1599591833 @default.
- W1599591833 citedByCount "0" @default.
- W1599591833 crossrefType "journal-article" @default.
- W1599591833 hasAuthorship W1599591833A5023276777 @default.
- W1599591833 hasConcept C126322002 @default.
- W1599591833 hasConcept C143998085 @default.
- W1599591833 hasConcept C168563851 @default.
- W1599591833 hasConcept C27740335 @default.
- W1599591833 hasConcept C2776364478 @default.
- W1599591833 hasConcept C2777478702 @default.
- W1599591833 hasConcept C2778367456 @default.
- W1599591833 hasConcept C2780401358 @default.
- W1599591833 hasConcept C71924100 @default.
- W1599591833 hasConcept C86803240 @default.
- W1599591833 hasConcept C95444343 @default.
- W1599591833 hasConceptScore W1599591833C126322002 @default.
- W1599591833 hasConceptScore W1599591833C143998085 @default.
- W1599591833 hasConceptScore W1599591833C168563851 @default.
- W1599591833 hasConceptScore W1599591833C27740335 @default.
- W1599591833 hasConceptScore W1599591833C2776364478 @default.
- W1599591833 hasConceptScore W1599591833C2777478702 @default.
- W1599591833 hasConceptScore W1599591833C2778367456 @default.
- W1599591833 hasConceptScore W1599591833C2780401358 @default.
- W1599591833 hasConceptScore W1599591833C71924100 @default.
- W1599591833 hasConceptScore W1599591833C86803240 @default.
- W1599591833 hasConceptScore W1599591833C95444343 @default.
- W1599591833 hasIssue "7" @default.
- W1599591833 hasLocation W15995918331 @default.
- W1599591833 hasOpenAccess W1599591833 @default.
- W1599591833 hasPrimaryLocation W15995918331 @default.
- W1599591833 hasRelatedWork W13185593 @default.
- W1599591833 hasRelatedWork W1503285048 @default.
- W1599591833 hasRelatedWork W1967877547 @default.
- W1599591833 hasRelatedWork W1979038330 @default.
- W1599591833 hasRelatedWork W1981921327 @default.
- W1599591833 hasRelatedWork W1987710106 @default.
- W1599591833 hasRelatedWork W1991414066 @default.
- W1599591833 hasRelatedWork W1996149688 @default.
- W1599591833 hasRelatedWork W1996965637 @default.
- W1599591833 hasRelatedWork W2020119933 @default.
- W1599591833 hasRelatedWork W2044477514 @default.
- W1599591833 hasRelatedWork W2056686464 @default.
- W1599591833 hasRelatedWork W2076977630 @default.
- W1599591833 hasRelatedWork W2088675711 @default.
- W1599591833 hasRelatedWork W2130781588 @default.
- W1599591833 hasRelatedWork W2413642590 @default.
- W1599591833 hasRelatedWork W2463626763 @default.
- W1599591833 hasRelatedWork W2593825509 @default.
- W1599591833 hasRelatedWork W2783534173 @default.
- W1599591833 hasRelatedWork W3024957951 @default.
- W1599591833 hasVolume "2" @default.
- W1599591833 isParatext "false" @default.
- W1599591833 isRetracted "false" @default.
- W1599591833 magId "1599591833" @default.
- W1599591833 workType "article" @default.